About Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Market Cap
$0.00B
Employees
7
Listed Since
July 27, 2018
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.adialpharma.comPhone
434-422-9800
Headquarters
1180 SEMINOLE TRAIL
CHARLOTTESVILLE, VA 22901
CIK
0001513525